Prologis Inc vs Stryker Corporation — how do they compare? Prologis Inc trades at $129.49 (market cap $122.87B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Prologis Inc is the larger of the two by market cap, and Prologis Inc pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Prologis Inc for 102 Days and Stryker Corporation for 21 Days on average.
| PLD | SYK | |
|---|---|---|
Market Cap | $122.87B | $106.24B |
Volume | 4,222,957 | 2,982,001 |
Sector | Real Estate | Health |
52-Week High | $149.96 | $388.35 |
52-Week Low | $111.23 | $269.75 |
Typical Hold Time | 102 Days | 21 Days |
Enterprise Value | $157.61B | $117.70B |
Dividend Yield | 3.31% | 1.27% |
Signals from Pluang's Aura AI — not financial advice
PLD trades at $129.29, up 1.56% today, with a bearish technical signal but strong fundamentals. Recent earnings consistently beat estimates, with Q2 2026 EPS of $1.13 versus $0.747 expected. The company shows robust revenue growth, reaching $8.79B in 2025, and maintains high profitability with a net income margin of 45.79%. News highlights leasing surges and data center growth, supporting a positive long-term outlook despite near-term price volatility.
The outlook for PLD is positive, driven by strong industrial REIT demand, earnings beats, and a consensus price target of $155.15 offering ~20% upside. Risks include rising debt-to-asset ratios (37.2% in 2025) and macroeconomic sensitivity. Analyst sentiment is bullish with 59.52% buy ratings, but investors should monitor debt levels and interest rate impacts on valuation.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →